Celldex Therapeutics Inc. (CLDX) Statistics & Valuation Metrics - Stocknear

Celldex Therapeutics Inc.

NASDAQ: CLDX · Real-Time Price · USD
22.78
-0.83 (-3.52%)
At close: Sep 04, 2025, 3:59 PM
22.78
0.00%
After-hours: Sep 04, 2025, 05:59 PM EDT

Celldex Therapeutics Statistics

Share Statistics

Celldex Therapeutics has 66.41M shares outstanding. The number of shares has increased by 0.16% in one year.

66.41M
0.16%
0.02%
99.99%
64.52M
45
n/a

Short Selling Information

The latest short interest is 7.31M, so 11.01% of the outstanding shares have been sold short.

7.31M
11.01%
13.01%
6.19

Valuation Ratios

The PE ratio is -10.31 and the forward PE ratio is -5.34. Celldex Therapeutics's PEG ratio is 0.64.

-10.31
-5.34
231.8
497.5
2.18
-10.19
0.64
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Celldex Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 18.91, with a Debt / Equity ratio of 0.01.

18.91
18.91
0.01
-0.02
-0.02
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$37.74K
$-848.73K
186
0.01
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -46.99% in the last 52 weeks. The beta is 1.22, so Celldex Therapeutics's price volatility has been higher than the market average.

1.22
-46.99%
22.35
22.09
55.63
1,202,174

Income Statement

In the last 12 months, Celldex Therapeutics had revenue of 7.02M and earned -157.86M in profits. Earnings per share was -2.45.

7.02M
7.02M
-195.08M
-157.86M
-191.9M
-195.08M
-2.45
Full Income Statement

Balance Sheet

The company has 28.36M in cash and 3.81M in debt, giving a net cash position of 24.54M.

28.36M
3.81M
24.54M
-1.56B
692.41M
615.44M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -157.78M and capital expenditures -1.92M, giving a free cash flow of -159.7M.

-157.78M
-1.92M
-159.7M
-2.48
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -2778.89% and -2248.76%.

100%
-2778.89%
-2248.76%
-2248.76%
-2733.63%
-2778.89%
-2274.89%

Dividends & Yields

CLDX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for CLDX is $42.5, which is 80% higher than the current price. The consensus rating is "Buy".

$42.5
80%
Buy
9
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Feb 11, 2019. It was a backward split with a ratio of 1:15.

Feb 11, 2019
backward
1:15

Scores

20.34
2